Prevalence of Insomnia and Hypnotic Use in Norwegian Patients Visiting Their General Practitioner
Overview
Affiliations
Background: Sleep problems are common in the general population, but there are few studies on the prevalence of sleep problems and hypnotic use among patients in general practice.
Objectives: To estimate the prevalence of insomnia (based on the Diagnostic and Statistical Manual of Mental Disorders [DSM], version 5), self-reported sleep problems and hypnotic use among patients in general practice, and explore whether the prevalence depended on patient characteristics.
Methods: A cross-sectional study with questionnaire data collected by 114 final-year medical students while deployed in different general practices in Norway during 2020. A total of 1,848 consecutive and unselected patients (response rate 85.2%) visiting their general practitioners (GPs) completed a one-page questionnaire, that included the validated Bergen Insomnia Scale (BIS), questions on for how long they have had a sleep problem, hypnotic use, and background characteristics. Associations were estimated using a modified Poisson regression model.
Results: The prevalence of chronic insomnia according to BIS was 48.3%, while 46.9% reported chronic sleep problems (sleep problems of ≥3 months) and 17.8% reported hypnotic use. Females, patients with low compared with higher education, and patients who slept shorter or longer than 7-8 h, had higher risk of chronic insomnia disorder (CID), chronic self-reported sleep problems (CSP), and hypnotic use. The oldest age group (≥65 years) had lower risk of chronic insomnia compared with the youngest (18-34) but twice the probability of hypnotic use.
Conclusions: CID, CSP, and hypnotic use were prevalent among patients visiting their GP. Insomnia can be effectively treated and deserves more attention among GPs.
Sayed Ahmed H, Abo El-Ela S, Joudeh A, Moawd S, El Hayek S, Shah J Obes Facts. 2024; 17(3):274-285.
PMID: 38484714 PMC: 11149973. DOI: 10.1159/000538341.
Psychometric properties of the Global Psychotrauma Screen in the United States.
Grace E, Rogers R, Usher R, Rivera I, Elbakry H, Sotilleo S Health Psychol Behav Med. 2023; 11(1):2266215.
PMID: 37811317 PMC: 10557551. DOI: 10.1080/21642850.2023.2266215.
Forthun I, Eliassen K, Emberland K, Bjorvatn B Front Psychiatry. 2023; 14:1033034.
PMID: 36937728 PMC: 10017838. DOI: 10.3389/fpsyt.2023.1033034.